Nov202024Tribunal fines drug firms £69m for excessive pricing after CMA investigation HM Government TwitterLinkedinFacebookemailFirms which raised prices for key epilepsy medicine – causing NHS costs to soar to £50 million – found by the CAT to have breached competition law. Follow this news feed:
